WO2008075942A1 - N-substituted-p-menthane-3-carboxamide and uses thereof - Google Patents
N-substituted-p-menthane-3-carboxamide and uses thereof Download PDFInfo
- Publication number
- WO2008075942A1 WO2008075942A1 PCT/NL2007/050609 NL2007050609W WO2008075942A1 WO 2008075942 A1 WO2008075942 A1 WO 2008075942A1 NL 2007050609 W NL2007050609 W NL 2007050609W WO 2008075942 A1 WO2008075942 A1 WO 2008075942A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- products
- receptor stimulant
- cold receptor
- substances
- isopropyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/204—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- the present invention relates to substances and compositions having a physiological cooling effect on the skin and the mucosa of the body, especially of the oral cavity, throat and nose. More in particular, the present invention relates to N- substituted-p-menthane-3-carboxamides and especially to flavour and/or fragrance compositions comprising such a substance, the use thereof for imparting or enhancing a physiological cooling effect in a consumer product, and to consumer products comprising such a substance.
- flavour s and fragrances for consumer products such as foodstuffs, beverages, tobacco products and personal care products
- compounds having a physiological cooling activity on the nervous system of the body, especially of the skin and the mucosa of the oral cavity, similar to that obtained with menthol there has always been great interest in compounds having a physiological cooling activity on the nervous system of the body, especially of the skin and the mucosa of the oral cavity, similar to that obtained with menthol.
- Such compounds may be added to ingestible preparations, to tobacco products, and/or to products applied to the skin, for the purpose of stimulating the cold receptors of the nervous system in the surface tissues of the mucosa of the oral cavity or the skin, thereby creating a sensation of coolness and/or freshness in the mouth or on the skin.
- Menthol has been used extensively for this purpose, and mainly as a fortifier for peppermint flavours (see “Perfume and Flavour Chemicals, Volume II, by Steffen Arctander, published 1969, Item No. 1840) but also in trace amounts in imitation butter, caramel, fruit complexes and licorice flavourings. Menthol is well known for its physiological cooling effect on the skin and mucous membranes of the mouth and has been extensively used as a flavouring agent (menthol being a major constituent of oil of peppermint) in foodstuffs, beverages, dentifrices, mouthwashes, etc. and as a component in a wide range of toiletries, liniments and lotions for topical application.
- Menthol is also a well known tobacco additive for producing a "cool" sensation in the mouth when smoking.
- menthol is a physiological effect due to the direct action of menthol on the nerve endings of the human body responsible for the detection of hot or cold and is not due to latent heat of evaporation. It is believed that the menthol acts as a direct stimulus on the cold receptors at the nerve endings which in turn stimulate the central nervous system.
- menthol is well established as a physiological coolant, its use in some compositions is impaired by its strong minty odour and its relative volatility.
- N-substituted-p-menthane-3- carboxamides having the property of stimulating the cold receptors of the nervous system of the human body to produce a cold sensation. These compounds have little or no odour, are of relatively low volatility and are substantially non- toxic. According to US 4,136,163 the cooling sensation created by these N-substituted carboxamides on the skin, and mucous membranes, for example in the mouth, varies both in intensity and longevity from compound to compound. In US 4,136,163 one alkylphenyl substituted p-menthane-3-carboxamide is disclosed.
- Flavorist Vol. 29, No. 8, pp. 34-50 (2004).
- Patent No. 2004059474 a new series of cooling compounds based on alkyloxy amides of p-menthane has been disclosed.
- WO 2005/049553 and WO 2006/049553 both disclose N-substituted-p- menthane-3-carboxamides wherein the carboxamide-substituent is a substituted aromatic which is connected to said carboxamide moiety directly, i.e. through a covalent bond, or through an unsubstituted methylene group.
- ffi and esters thereof are capable of imparting and/or enhancing a physiological cooling effect in a product in which they are incorporated, much more effectively than the heretofore known N-substituted-p-menthane-3-carboxamides, more in particular, this substance was found to be significantly more potent, especially strong er and/or longer-lasting, than any of the prior art N-substituted-p-menthane-3-carboxamides.
- a very intense and/or very longer lasting physiological cooling effect can be imparted in a consumer product selected from foodstuffs, beverages, oral care products, cosmetic products, personal care products and tobacco products, by the incorporation of an effective amount of one or more of the aforementioned cold receptor stimulants represented by said formula (I) and/or edible esters thereof, said effective amount being unexpectedly low.
- the strength of the present cold receptor stimulant is considerably higher than that of WS-3, approximately a factor 10 higher, and that of WS-5, which so far has been assumed to constitute the most potent cold receptor stimulant of the N- substituted-p-menthane-3 -carboxamide family.
- Trp-p8 which is a cation channel protein, preferentially expressed in the prostate and found over-expressed in a range of cancers, including prostate, breast, lung and colon cancer.
- modulation of Trp-p8 activity by activation with an agonist can be valuable as a therapeutic to manipulate the Trp- p8 expressing cells in a specific manner, typically inhibiting growth thereof and/or inducing apoptosis and/or necrosis thereof.
- Oral or topical administration of said substance is not disclosed, the preferred route of administration is parenteral.
- Nothing is disclosed in WO 2005/020897 teaching or suggesting the skilled person that the substances of the present invention impart and/or enhance physiological cooling effects on the skin and/or mucosa.
- the present invention provides for the first time the substances represented by the aforementioned formula (I) and their use as a cold receptor stimulant for imparting and/or enhancing a physiological cooling effect in a consumer product, especially in a consumer product selected from foodstuffs, beverages, oral care products, cosmetic products, personal care products and tobacco products.
- the invention also provides cooling compositions comprising one or more of the present cold receptor stimulants as well as one or more flavour imparting substances and/or fragrance materials, which can suitably be applied for imparting and/or enhancing said cooling effects as well as methods of imparting and/or enhancing a physiological cooling effect therein, especially coolness and/or freshness.
- a first aspect of the invention concerns a cold receptor stimulant selected from the group of substances of the following formula (I):
- R represents hydrogen, hydroxyl, oxo, lower alkyl or lower alkoxyl
- R' represents hydrogen or lower alkyl
- X and Y independently represent hydrogen, hydroxyl, lower alkyl and lower alkoxyl; and wherein the dashed lines represent an optional additional bond or an optional C 1 -
- a preferred embodiment of this invention concerns cold receptor stimulants as defined above selected from the group of substances of the following formula (II):
- R represents hydrogen, hydroxyl, lower alkyl or lower alkoxyl; and esters thereof.
- the present inventors have found that the above-mentioned cold receptor stimulants a re very useful ingredients for application in foodstuffs, beverages, personal care products and tobacco products, said cold receptor stimulants being capable of imparting and/or enhancing a physiological cooling effect in a product to which it is added.
- physiological cooling effect is used to describe the specific sensorial impact that is perceived via the skin and mucosa, especially in the oral and nasal cavities as well as the throat.
- the term 'esters thereof encompasses any derivative of the present cold receptor stimulant and an acid formed by reaction of said acid with the hydroxyl group present in said substance.
- said esters are edible, typically they are not significantly more toxic than the cold receptor stimulant represented by formula (I).
- said acid is an organic acid such as a substituted or non- substituted, linear or branched Ci-C 6 carboxylic acid, more preferably a C1-C4 carboxylic acid, most preferably a C1-C3 carboxylic acid, or alternatively an inorganic acid such as phosphoric acid.
- organic acid such as a substituted or non- substituted, linear or branched Ci-C 6 carboxylic acid, more preferably a C1-C4 carboxylic acid, most preferably a C1-C3 carboxylic acid, or alternatively an inorganic acid such as phosphoric acid.
- the cold receptor stimulant is selected from the group consisting of substances of formula (I).
- lower as used herein in connection to the term “alkoxyl” and “alkyl”, means that the moiety concerned comprises a carbon chain portion of not more than six carbon atoms, preferably of not more than four carbon atoms, most preferably of not more than two carbon atoms.
- the lower alkyl is a branched or unbranched saturated Ci-C 6 alkyl, prefably C1-C4 alkyl, most preferably Ci -C 2 alkyl.
- the lower alkoxyl is a branched or unbranched saturated Ci-C 6 alkoxyl, preferably C 1-C4 alkoxyl, most preferably C1-C2 alkoxyl.
- a cold receptor stimulant as defined herein before is selected wherein R represents hydrogen, hydroxyl, methyl, ethyl, methoxy, ethoxy, isopropoxy, and propoxy; R' represents hydrogen, methyl or ethyl; X and Y independently represent hydrogen, methyl, ethyl, propyl, isopropyl, hydroxyl, methoxy, ethoxy, isopropoxy or propoxy and the dashed lines represent an optional double bond or an optional methylene moiety.
- R in formula (I) and (II) represents hydrogen, hydroxyl, met hoxy or methyl most preferably hydrogen or hydroxyl.
- R in formula (I) or (II) represents hydrogen
- R' represents hydrogen, hydroxyl, methoxy or methyl ,most preferably hydrogen.
- X and Y in formula (I) represent hydrogen, hydroxyl, methyl, ethyl, methoxy or ethoxy , more preferably hydrogen, methyl, methoxy or ethoxy. It is furthermore particularly preferred that X is in the meta or para position. It is furthermore particularly preferred that Y is in the ortho or meta position. Most preferably X and Y are chosen such that aromatic radical in formula (I) represents one of the following: an unsubstituted phenyl radical; a 2- ethoxyphenyl radical and a 3,4-dimethylphenyl radical.
- the dashed lines indicate the optional presence of an additional covalent bond or of a Ci-C 2 alkylene moiety, preferably a methylene moiety, said moiety forming a cyclic structure together with the carbon atoms to which it is attached.
- the present inventors believe that the presence of the additional bond or the alkylene moiety limit the rotational degrees of freedom are restricted as compared to a corresponding structure without the additional bond or alkylene moiety, thereby increasing the cold receptor stimulating efficacy of the structure.
- the present cold receptor stimulants comprise an additional covalent bond or a Ci-C 2 alkylene moiety at the position indicated by the dashed lines in formula (I).
- cold receptor stimulants include 2-isopropyl-5-methyl-cyclohexanecarboxylic acid (2-hydroxy-2- phenylethyl)-amide, 2 -isopropyl-5-methyl-cyclohexanecarboxylic acid phenylethyl- amide, N-(2-ethoxyphenethyl)-2-isopropyl-5-methylcyclohexanecarboxamide,
- a second aspect of the present invention concerns compositions comprising a cold receptor stimulant represented by the above formula (I) or (II), wherein R, R', X, Y and the dashed lines have the same meaning as defined above, as well as at least 0.1 wt% of one or more flavour imparting substances and/or one or more fragrance imparting substances.
- compositions typically constitute flavour compositions or fragrance compositions.
- Such compositions are not regarded as consumer products, i.e. are not suitable for consumption and/or use by a consumer as such, but are suited for application in such consumer products, in order to impart or enhance therein the physiological cooling effects, as will be understood by the person skilled in the art.
- the present flavour or fragrance compositions comprise the cold receptor stimulant of the invention in an amount of at least 2 ppm, calculated on dry solids weight, preferably in an amount within the range of 5-100,000 ppm, more preferably within the range of 10-50,000 ppm, most preferably within the range of 50- 10,000 ppm.
- ppm refers to amounts expressed in parts per million, whereby 1 ppm corresponds to 1 mg/kg, in accordance with its usual meaning in the art of flavours and fragrances.
- flavour imparting substance encompasses any food grade substance that is capable of imparting a detectable sensory impact that is perceived via the mouth, especially the tongue, and the olfactory epithelium in the nasal cavity, typically at concentrations below 1 wt.%, more preferably below 0.1 wt.%.
- flavour imparting substances include alcohols, aldehydes, ketones, esters, ethers, acetates, nitriles, terpene hydrocarbons, nitrogenous or sulphurous heterocyclic compounds.
- one or more flavour imparting substances may be comprised in essential oils.
- Flavour impart ing substances in accordance with the invention can be of natural or synthetic origin. Many of these are listed in reference texts such as the book by S. Arctander, Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA, or its more recent versions, or in other works of a similar nature, as well as in the abundant patent literature in the field of flavours. It will be clear to the skilled person that the type of flavour impart ing substance added would entirely depend on the type of consumer product to which the composition is added.
- compositions as defined herein before comprising one or more flavouring substance containing oils, preferably selected from peppermint oil, spearmint oil, other mint oils, clove oil, oil of wintergreen, oil of eucalyptus, oil of anise, and oil of cinnamon.
- the composition according to the invention comprises one or more flavour imparting substances in an amount of at least 0.1 wt%, calculated on dry solids weight, preferably in an amount within the range of 0.5- 99.wt%, more preferably within the range of 1-50 wt%, most preferably within the range of 2-25 wt%.
- fragrance imparting substance is used to indicate any odouriferous substance that is used to impart an overall pleasant odor profile to a composition, particularly a cosmetic composition or personal care product.
- a wide variety of substances are useful as fragrance imparting substances, including e.g. aldehydes, ketones and esters, which may be synthetic or may be derived from naturally occurring plant or animal sources.
- Naturally occurring plant and animal oils and exudates comprising complex mixtures of various fragrance imparting substances are known as well for use as fragrance materials.
- Fragrance imparting substances that may suitably be used in accordance with this invention include pro -fragrances such as acetal pro -fragrances, ketal pro-fragrances, ester pro-fragrances, hydrolysable inorganic-organic pro -fragrances and mixtures thereof. Lists of suitable fragrance imparting substances as well as materials comprising them can be found in Journals used by those in the art such as “Perfume and Flavourist” or "Journal of Essential Oil Research”.
- one or more fragrance imparting substances are comprised in the composition of the invention at a level within the range of 0.5-99 wt.%, calculated on dry solids weight.
- the one or more fragrance imparting substances are present at a level within the range of 1-50 wt%, most preferably within the range of 2- 25 wt%, by dry weight of the composition.
- the cold receptor stimulant and the one or more flavour impart ing substances or the one or more fragrance imparting substances as defined herein before are employed in a weight ratio within the range of 0.001-10, preferably within the range of 0.01-1, most preferably within the range of 0.05-0.5.
- the present cooling composition comprises a further cold receptor stimulant.
- Suitable examples thereof include menthol, WS-3, WS-23, WS-5, menthyl-lactate, menthoxypropane-l,2-diol,
- composition according to the present invention may suitably be prepared in the form of a liquid, a paste or a powder, further comprising a carrier material, such as maltodextrin, modified starch, gum Arabic, ethanol or propylene glycol.
- a carrier material such as maltodextrin, modified starch, gum Arabic, ethanol or propylene glycol.
- composition is a flavour composition it is particularly preferred that the composition is a free flowing powder.
- flavour compositions comprise a food grade carrier material, i.e. a carrier material which is non-toxic and does not significantly affect the organoleptic properties of the combination of the cold receptor stimulant and the one or more flavour imparting substances.
- a composition comprising a cold receptor stimulant and one or more flavour impart ing substances as defined herein before, wherein one or more of said components are encapsulated in a matrix, typically a carbohydrate matrix, which is suitable for retaining volatile components and forms a barrier to oxygen and/or moisture.
- a matrix typically a carbohydrate matrix, which is suitable for retaining volatile components and forms a barrier to oxygen and/or moisture.
- one or more of said components are encapsulated in a controlled release matrix, e.g. for chewing gum applications, such as the matrices described in
- a consumer product selected from foodstuffs, beverages, oral care products, cosmetic products, personal care products and tobacco products, comprising a cold receptor stimulant as defined herein before, in an amount effective to impart or enhance therein a physiological cooling effect.
- a consumer product is provided as defined herein before, wherein said amount is an amount ranging from 0.0001 to 500 ppm, based on the total weight of said product, preferably an amount ranging from 0.0005 to 50, more preferably ranging from 0.001 to 10 ppm, most preferably ranging from 0.002 to 5 ppm.
- said consumer product is a foodstuff selected from the group of confectioneries, including hard and soft candies, chewing gum, edible films, lozenges and pastilles, desserts and ice cream; a beverage selected from the group of soft drinks, alcoholic beverages and dairy drinks; an oral care product selected from the group of toothpastes, mouthwashes, dental floss, anti-plaque and anti-gingivitis compositions; a personal care product selected from the group of deodorants, shampoos, skin sanitizing compositions, lotions and shaving products; or a tobacco product selected from the group of smoking tobacco, chewing tobacco as well tobacco substitute products.
- a foodstuff selected from the group of confectioneries, including hard and soft candies, chewing gum, edible films, lozenges and pastilles, desserts and ice cream
- a beverage selected from the group of soft drinks, alcoholic beverages and dairy drinks
- an oral care product selected from the group of toothpastes, mouthwashes, dental floss, anti-plaque and anti-gingivitis compositions
- a consumer product as defined herein before is provided, wherein said consumer product further comprises at least one, preferably at least two, most preferably at least three other flavour imparting substances or fragrance imparting substances as defined herein before.
- a cold receptor stimulant as defined herein before is provided, for imparting and/or enhancing a physiological cooling effect in a consumer product selected from foodstuffs, beverages, oral care products, cosmetic products, personal products and tobacco products.
- the use comprises incorporation of the cold receptor stimulant in said products in the amounts recited here above.
- a method of imparting or enhancing a physiological cooling effect in a consumer product selected from foodstuffs, beverages, oral care products, cosmetic products, personal care products and tobacco products comprising incorporating in said product an effective amount of a cold receptor stimulant as defined herein before.
- a method as defined herein before is provided, wherein said amount is an amount ranging from 0.0001 to
- Still another aspect of the invention provides a method of preparing the cold receptor stimulant represented by formula (I) or (II), or an ester or a salt thereof. Typically said process comprises reacting a menthane carboxylic acid with an amine represented by the following formula (III):
- the menthane carboxylic acid is preferably an activated menthane carboxylic acid, i.e a menthane carboxylic acid that is more reactive than the original carboxylic acid, as is understood by the person skilled in the art.
- activated carboxylic acid typically encompasses (mixed) anhydrides, esters, acid chlorides or acid bromides of the carboxylic acid, as will be recognized by the skilled person.
- the process typically comprises combining the aforementioned starting materials and heating the mixture.
- the present method of preparing flavour modulating substances comprises processes that make use of conventional reactions. Preferably said reaction is performed by heating the reactants in an organic solvent or a mixture of organic solvents, e.g. DMF/pyridine, for a period of between 0.1-10 hours.
- the reaction products can typically be isolated by evaporating the solvent and optionally further purified using any of the techniques known by the skilled person, such as chromatography and crystallization.
- Example 3 Comparative sensorial evaluation of the product of example 1
- Solution A was described as: “cooling”
- Solution B was described as: “high initial cooling burst”, “long-lasting cooling”, “cold perception in whole mouth”, “some hotness”
- Solution C was described as: “more neutral cold perception than B”, “less aggressive cooling than B”, “less long-lasting cooling than B”
- Solution D was described as: “more neutral cold perception than B”, “less aggressive cooling than B”, “less long-lasting cooling than B”
- Solution B has a comparable strength to solution C and is much stronger than solution D.
- Example 4 Comparative sensorial evaluation of the product of example 2 Four aqueous solutions were prepared:
- solution A was described as: “cooling”
- solution B was described as: “cold perception with a pain sensation”, “aggressive, long-lasting cooling”, “almost noxious cold”, “slightly tingling”
- solution C was described as: “more neutral cold perception than B”, “less aggressive cooling than B”, “less long-lasting cooling than B”
- solution D was described as: “more neutral cold perception than B", “less aggressive cooling than B", “less long-lasting cooling than B”
- solution B has a comparable strength to solution C and is much stronger than solution D.
- Example 5 Hard boiled sweets containing cold receptor stimulant; comparative example.
- Table 1 hard boiled sweets formulation.
- the sweets were prepared according to the following procedure. Sugar, water and glucose syrup are mixed and boiled till 146 0 C. The mix is cooled to 120 0 C, the cold receptor stimulant is added and carefully mixed in. The mix is poured on a cooling table and folded in and molded on a roller.
- the sweets prepared were evaluated by a panel of experienced flavourists.
- Product A was described as “giving coolness and a cold perception” and “having an immediate cooling effect” and “not longlasting”.
- Product A containing WS-3 gives at a dosage of 50 ppm WS-3 an irritating feeling in the throat.
- Product B comprising the product prepared in example 1 , was described as “giving a cold sensation which is not irritating” and “much more longlasting than A”. The effect of product B is in the whole mouth and has a tingling-cool aftertaste.
- Product C comprising the product prepared in example 2, was described as “slow release cooling", “giving a cold effect in the whole mouth", “tingling pain sensation enhancing the cooling effect and "very longlasting". The strength of products A, B and C are comparable.
- Example 5 Preparation of N-(2-ethoxyphenethyl)-2-isopropyl-5-methylcyclohexane- carboxamide The title compound was prepared following the general procedure of Example 1.
- Example 6 Preparation of 2-isopropyl-5-methyl-N-((lS,2S)-2-phenylcyclopropyl)- cyclohexanecarboxamide.
- Example 7 Preparation of N-(3,4-dimethylphenethyl)-2-isopropyl-5-ethylcyclo- hexanecarboxamide. The title compound was prepared following the general procedure of Example
- Example 8 Preparation of N-(4-hyrdoxyphenethyl)-2-isopropyl-5-methylcyclo- hexanecarboxamide.
- GC-MS 303 (M), 288, 184, 139, 120, 107, 83, 69, 55, 41, 30.
- Example 10 Comparative sensorial evaluation of the products of examples 5-9
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07851869A EP2104436A1 (en) | 2006-12-20 | 2007-11-30 | N-substituted-p-menthane-3-carboxamide and uses thereof |
BRPI0721140-6A BRPI0721140A2 (en) | 2006-12-20 | 2007-11-30 | P-MENTANE-3-N-REPLACED CARBOXAMIDE AND USES OF THE SAME. |
US12/519,801 US20100056636A1 (en) | 2006-12-20 | 2007-11-30 | N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof |
JP2009542671A JP2010513657A (en) | 2006-12-20 | 2007-11-30 | N-substituted-p-menthane-3-carboxamides and uses thereof |
MX2009006695A MX2009006695A (en) | 2006-12-20 | 2007-11-30 | N-substituted-p-menthane-3-carboxamide and uses thereof. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06126622 | 2006-12-20 | ||
EP06126622.7 | 2006-12-20 | ||
US98246407P | 2007-10-25 | 2007-10-25 | |
US60/982,464 | 2007-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008075942A1 true WO2008075942A1 (en) | 2008-06-26 |
Family
ID=38261465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2007/050609 WO2008075942A1 (en) | 2006-12-20 | 2007-11-30 | N-substituted-p-menthane-3-carboxamide and uses thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US20100056636A1 (en) |
EP (1) | EP2104436A1 (en) |
JP (1) | JP2010513657A (en) |
KR (1) | KR20090113829A (en) |
CN (1) | CN101583287A (en) |
BR (1) | BRPI0721140A2 (en) |
MX (1) | MX2009006695A (en) |
WO (1) | WO2008075942A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010019729A1 (en) * | 2008-08-15 | 2010-02-18 | The Procter & Gamble Company | Solution of menthane carboxamides for use in consumer products |
WO2014009374A1 (en) * | 2012-07-09 | 2014-01-16 | Givaudan Sa | 3-substituted para-methane derivatives |
WO2014009416A1 (en) * | 2012-07-10 | 2014-01-16 | Givaudan Sa | 3-substituted para-menthane derivatives |
WO2017070083A1 (en) * | 2015-10-22 | 2017-04-27 | The Procter & Gamble Company | Shampoo with a cooling sensation compound |
US9949505B2 (en) | 2012-04-30 | 2018-04-24 | Philip Morris Products S.A. | Smoking article mouthpiece with cooling agent inclusion complex |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2318356B1 (en) * | 2008-08-15 | 2015-03-11 | The Procter & Gamble Company | Synthesis of cyclohexane derivatives useful as sensates in consumer products |
BR112014004523A2 (en) * | 2011-09-01 | 2017-03-28 | Takasago Int Corp (U S A ) | flavoring compound and composition |
CA2882090C (en) * | 2012-09-28 | 2018-07-10 | The Gillette Company | A skin engaging member comprising at least one thermally resilient sensate |
JP2015019658A (en) * | 2013-07-24 | 2015-02-02 | 三栄源エフ・エフ・アイ株式会社 | Gelatinous food and drink products having effect for facilitating deglutition |
WO2016036423A2 (en) | 2014-04-23 | 2016-03-10 | The Procter & Gamble Company | Compositions for deposition on biological surfaces |
JP6740901B2 (en) * | 2014-07-11 | 2020-08-19 | ライオン株式会社 | Oral composition and method for suppressing taste of cationic bactericide in oral composition |
SG11201906365VA (en) | 2017-01-10 | 2019-08-27 | Takasago Perfumery Co Ltd | Methylmenthol derivative and cool-sensation imparter composition containing same |
WO2019078185A1 (en) * | 2017-10-16 | 2019-04-25 | 高砂香料工業株式会社 | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative |
CN111032003B (en) * | 2017-12-21 | 2023-03-17 | 弗门尼舍有限公司 | Cooling and flavor enhancing compositions |
GB201807305D0 (en) * | 2018-05-03 | 2018-06-20 | Nicoventures Trading Ltd | Vaporisable formulation |
JP2022104290A (en) * | 2020-12-28 | 2022-07-08 | ライオン株式会社 | Composition for oral cavity |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136163A (en) * | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
US4193936A (en) * | 1971-02-04 | 1980-03-18 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
WO2005020897A2 (en) * | 2003-08-22 | 2005-03-10 | Dendreon Corporation | Compositions and methods for the treatment of disease associated with trp-p8 expression |
WO2005049553A1 (en) * | 2003-11-21 | 2005-06-02 | Givaudan Sa | N-substituted p-menthane carbosamided |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4150052A (en) * | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4296093A (en) * | 1973-04-16 | 1981-10-20 | Wilkinson Sword Limited | Cyclic carboxamides having a physiological cooling effect |
US4285984A (en) * | 1976-08-09 | 1981-08-25 | Givaudan Corporation | Flavoring with dialkylamino-alkylene mercaptans and sulfides |
GB0221697D0 (en) * | 2002-09-18 | 2002-10-30 | Unilever Plc | Novel compouds and their uses |
CA2497910A1 (en) * | 2002-10-28 | 2004-05-06 | Givaudan Sa | Coolant solutions and compositions comprising the same |
WO2004043165A1 (en) * | 2002-11-14 | 2004-05-27 | Givaudan Sa | Edible film containing food acid |
GB0313173D0 (en) * | 2003-06-07 | 2003-07-16 | Givaudan Sa | Improvements in or related to organic compounds |
US6884906B2 (en) * | 2003-07-01 | 2005-04-26 | International Flavors & Fragrances Inc. | Menthyl half acid ester derivatives, processes for preparing same, and uses thereof for their cooling/refreshing effect in consumable materials |
US7189760B2 (en) * | 2004-04-02 | 2007-03-13 | Millennium Specialty Chemicals | Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine |
GB0425661D0 (en) * | 2004-11-23 | 2004-12-22 | Givaudan Sa | Organic compounds |
BRPI0607407A2 (en) * | 2005-03-01 | 2009-09-01 | Givaudan Sa | carboxamide menthane derivatives having refreshing properties |
GB0504194D0 (en) * | 2005-03-02 | 2005-04-06 | Givaudan Sa | Organic compounds |
WO2006099762A1 (en) * | 2005-03-24 | 2006-09-28 | Givaudan Sa | Cooling compounds |
CN101184470A (en) * | 2005-05-27 | 2008-05-21 | 吉万奥丹股份有限公司 | Cooling compounds |
WO2007022651A1 (en) * | 2005-08-22 | 2007-03-01 | Givaudan Sa | Substituted bicyclo [2.2.2] oct/5-ene compounds and their use as cooling agents |
ATE443046T1 (en) * | 2005-10-25 | 2009-10-15 | Givaudan Sa | ORGANIC COMPOUNDS |
WO2007104175A2 (en) * | 2006-03-15 | 2007-09-20 | Givaudan Sa | Para-substituted 2-alkoxyphenol compounds |
WO2008151460A2 (en) * | 2007-06-13 | 2008-12-18 | Givaudan Sa | Cooling compounds |
WO2009076792A1 (en) * | 2007-12-19 | 2009-06-25 | Givaudan Sa | Cooling compounds |
-
2007
- 2007-11-30 MX MX2009006695A patent/MX2009006695A/en unknown
- 2007-11-30 KR KR1020097014931A patent/KR20090113829A/en not_active Application Discontinuation
- 2007-11-30 CN CNA2007800502171A patent/CN101583287A/en active Pending
- 2007-11-30 WO PCT/NL2007/050609 patent/WO2008075942A1/en active Application Filing
- 2007-11-30 JP JP2009542671A patent/JP2010513657A/en active Pending
- 2007-11-30 BR BRPI0721140-6A patent/BRPI0721140A2/en not_active IP Right Cessation
- 2007-11-30 US US12/519,801 patent/US20100056636A1/en not_active Abandoned
- 2007-11-30 EP EP07851869A patent/EP2104436A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136163A (en) * | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
US4193936A (en) * | 1971-02-04 | 1980-03-18 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
WO2005020897A2 (en) * | 2003-08-22 | 2005-03-10 | Dendreon Corporation | Compositions and methods for the treatment of disease associated with trp-p8 expression |
WO2005049553A1 (en) * | 2003-11-21 | 2005-06-02 | Givaudan Sa | N-substituted p-menthane carbosamided |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010019729A1 (en) * | 2008-08-15 | 2010-02-18 | The Procter & Gamble Company | Solution of menthane carboxamides for use in consumer products |
US9949505B2 (en) | 2012-04-30 | 2018-04-24 | Philip Morris Products S.A. | Smoking article mouthpiece with cooling agent inclusion complex |
US10506824B2 (en) | 2012-04-30 | 2019-12-17 | Philip Morris Products S.A. | Smoking article mouthpiece with cooling agent inclusion complex |
WO2014009374A1 (en) * | 2012-07-09 | 2014-01-16 | Givaudan Sa | 3-substituted para-methane derivatives |
WO2014009416A1 (en) * | 2012-07-10 | 2014-01-16 | Givaudan Sa | 3-substituted para-menthane derivatives |
WO2017070083A1 (en) * | 2015-10-22 | 2017-04-27 | The Procter & Gamble Company | Shampoo with a cooling sensation compound |
Also Published As
Publication number | Publication date |
---|---|
EP2104436A1 (en) | 2009-09-30 |
BRPI0721140A2 (en) | 2014-04-01 |
MX2009006695A (en) | 2009-09-14 |
US20100056636A1 (en) | 2010-03-04 |
CN101583287A (en) | 2009-11-18 |
JP2010513657A (en) | 2010-04-30 |
KR20090113829A (en) | 2009-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100056636A1 (en) | N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof | |
JP3292883B2 (en) | Cool feeling composition | |
US5725865A (en) | Coolant compositions | |
US4178459A (en) | N-Substituted paramenthane carboxamides | |
EP3569671B1 (en) | Methylmenthol derivative and cool-sensation imparter composition containing same | |
US4226988A (en) | N-substituted paramenthane carboxamides | |
US4193936A (en) | N-substituted paramenthane carboxamides | |
EP1493336B1 (en) | Monomenthyl ester derivatives of dicarboxylic acids, processes for preparing same, and uses thereof for their cooling/refreshing effect in consumable materials | |
ES2377953T3 (en) | Conjugated dienamides, methods of preparation thereof, compositions containing them and uses thereof | |
EP2606746B2 (en) | Cooling enhancing compositions | |
JPS5940862B2 (en) | Improvements in compounds and compositions having a physiological cooling effect | |
JP2007510634A (en) | Use of alkenecarboxylic acid N-alkylamides as fragrances | |
EP2246323A1 (en) | Menthylcarboxamides and their use as cooling agents | |
JP2008115181A (en) | Nalpha-(MENTHANECARBONYL)AMINO ACID AMIDE AND USE THEREOF AS PHYSIOLOGICAL COOLING ACTIVE INGREDIENT | |
JP4608499B2 (en) | Aroma ingredients for refreshing preparations | |
US8377422B2 (en) | Carboxamide derivatives having cooling properties | |
JP6987839B2 (en) | Warm compound | |
US20110070171A1 (en) | 1-tert-Butylcyclohexanecarboxamide and uses thereof as cooling compounds | |
WO2006117602A2 (en) | Use of amide derivatives as taste-modifying agents, flavouring compositions and products containing them | |
JP2010527943A (en) | Buton derivatives useful as coolants | |
US8487130B2 (en) | Menthylcarboxamides and their use as cooling agents | |
JPS6041662A (en) | Trans, trans-delta-damascone | |
JP2009529545A (en) | Para-substituted 2-alkoxyphenol compounds | |
WO2001035918A1 (en) | Mint flavor and aroma compositions | |
ES2425188T3 (en) | E2, E4, Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780050217.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07851869 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3508/CHENP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2009542671 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/006695 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007851869 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097014931 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12519801 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0721140 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090622 |